Welcome to our dedicated page for Multiplan Corporation SEC filings (Ticker: MPLN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Claritev Corporation, formerly MultiPlan Corporation, files SEC reports that document its healthcare technology, data and insights business, consolidated subsidiaries and public-company capital structure. Recent Form 8-K filings cover quarterly operating results, Regulation FD investor presentations, and the company’s Class A common stock registered on the New York Stock Exchange under the CTEV ticker.
The filings also describe disclosure topics tied to the company’s operating model, including litigation and governmental proceedings, information-technology interruptions and cybersecurity risks, software licenses and usage rights, proprietary information, network infrastructure, market position, and other risks affecting its healthcare affordability, transparency and analytics platform.
Claritev Corporation filed a current report to let investors know it is making an updated slide presentation available on its website beginning on September 3, 2025. The presentation, attached as Exhibit 99.1, is meant to share information under Regulation FD, which is designed to ensure all investors receive material company information at the same time.
The company states that the slide deck and the related disclosure are being "furnished" rather than "filed," meaning they are not subject to certain liability provisions of the Exchange Act and are not automatically incorporated into other securities law filings unless specifically referenced.
White Dale A., a director of Claritev Corp (CTEV), reported transactions dated 08/21/2025 that moved 201,652 shares of Class A common stock from direct ownership into a revocable trust. The Form 4 shows a Code G transfer with a reported price of $0, indicating an internal transfer rather than a market sale. After the transfer the reporting person is shown with 160,080 shares held directly and 201,652 shares held indirectly by trust. The filing is signed by an attorney-in-fact on 08/25/2025.
Claritev Corp (CTEV) reporting person Dalton Travis, who is President, CEO & Executive Chair and a director, reported purchases of Class A common stock totaling 4,282 shares. The Form 4 shows a purchase of 300 shares on 08/08/2025 at a weighted average price of $54.2083 (individual trades ranged $54.18–$54.25) and a purchase of 3,982 shares on 08/11/2025 at a weighted average price of $58.3019 (individual trades ranged $58.06–$58.50). The shares are reported as indirectly beneficially owned in the reporting person’s spouse’s Individual Retirement Account, bringing indirect holdings to 4,282 shares. The Form 4 was executed by attorney-in-fact Kent Bartholomew and dated 08/12/2025.
Claritev Corporation reported that its Executive Vice President and Chief Operating Officer, Jerome Hogge, purchased 5,621 shares of Class A common stock on 08/07/2025 at a weighted average price of $53.5084 (individual trades ranged from $53.26 to $53.56). Following these purchases, Hogge's beneficial ownership increased to 90,023 shares.
The Form 4 notes the price shown is a weighted average for multiple transactions and that the reporting person will provide full breakdowns of the number of shares purchased at each price upon request. No derivative transactions are reported on this form.